FindTrial
Sign In

A CLINICAL STUDY ON PRIMITIVE CERVICAL CELL PATHOLOGY AND ITS AYURVEDIC MANAGEMENT

AN AYURVEDIC MANAGEMENT OF PRIMITIVE CERVICAL CELL PATHOLOGY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/006035
Enrollment
80
Registered
2015-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients after screening and diagnosed for cervical cell pathology will be registered for clinical trial

Interventions

Intervention1: Kasisadi Ksharakarma: Kshara will be applied after cessation of menses locally for once till Samyak Dagdha Lakshanas will be observed
over the erosion with the help of swab stick will be followed by Panchavalkala Kwath Yoni Prakshalana. After that Darvyadi Yoni varti of 1 tab. of 3gm once a day for 21 days. Intervention2: Darvyadi Y
over the erosion with the help of swab stick will be followed by Panchavalkala Kwath Yoni Prakshalana. After that Darvyadi Yoni varti of 1 tab. of 3gm once a day for 21 days. Group B Yoni Varti of 1 t
over the erosion with the help of swab stick will be followed by Panchavalkala Kwath Yoni Prakshalana. After that Darvyadi Yoni varti of 1 tab. of 3gm once a day for 21 days. Control Intervention1: Da

Sponsors

IPGT and RA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cervicitis, CIN I and II (As per Bethesda classification) in pap smear test Patients with clinical signs and symptoms of cervical cell pathology including white discharge, contact bleeding, backache, erosion, hypertrophy etc.

Exclusion criteria

Exclusion criteria: 1. Unmarried women will be excluded. 2. Women below 20 yrs and above 60 yrs. 3. Pregnant women & lactating mothers. Patients with following chronic illness will be excluded from study - Tuberculosis of uterus and endometrium Cervical polyp Procedentia CIN Grade III (As per Bethesda classification) Carcinoma of cervix. 5. Other chronic debilitating disorders such as TB, DM, etc.

Design outcomes

Primary

MeasureTime frame
1. Improvement in signs & symptoms of the disease. 2. Improvement in general condition of patients. 3. For subjective parameters especially on Ayurvedic parlance suitable scoring pattern shall be developed. Timepoint: fourty five days—

Secondary

MeasureTime frame
Changes in Pap smear reportTimepoint: fourty five days—

Countries

India

Contacts

Public ContactDr Shilpa B Donga

Institute for post Graduate teaching and research in ayurved

drshilpadonga@yahoo.com09825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026